
Singapore's Nuevocor raises $45 M to develop mechanobiology-centered therapy for cardiomyopathy
Singapore's Nuevocor raises $45 M to develop mechanobiology-centered therapy for cardiomyopathy May 6, 2025 | Tuesday | News Proceeds will support the Phase 1/2 clinical trial of lead candidate, NVC-001 image credit- shutterstock Nuevocor, a …